Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Y9RO
|
|||
| Former ID |
DCL000770
|
|||
| Drug Name |
Dexanabinol
|
|||
| Synonyms |
Sinnabidiol; HU 211; HU-211; PRS 211007-000; (6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; 1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol; 1,1-Dimethylheptyl-7-hydroxy-delta(6)-tetrahydrocannabinol; 11-Hydroxy-delta(8)-tetrahydrocannabinol-dimethylheptyl; 11-Hydroxy-delta-8-dmh-thc; 11-Hydroxymethyl-delta(8)-tetrahydrocannabinol-dimethylheptyl; 11-OH-delta(8)-Thc-dmh; 5'(1,1-Dimethylheptyl)-7-hydroxyhexahydrocannabinol; 7-Hydroxy-delta-6-tetrahydrocannabinoldimethylheptyl
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Traumatic brain injury [ICD-11: NA07.Z] | Phase 3 | [1] | |
| Company |
Pharmos
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H38O3
|
|||
| Canonical SMILES |
CCCCCCC(C)(C)C1=CC(=C2C3CC(=CCC3C(OC2=C1)(C)C)CO)O
|
|||
| InChI |
1S/C25H38O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h10,14-15,19-20,26-27H,6-9,11-13,16H2,1-5H3/t19-,20-/m0/s1
|
|||
| InChIKey |
SSQJFGMEZBFMNV-PMACEKPBSA-N
|
|||
| CAS Number |
CAS 112924-45-5
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
10234433, 14853924, 14902800, 44436736, 47660042, 50070448, 50071092, 57309703, 57338244, 71821373, 76631035, 93308095, 103369660, 103961937, 104379716, 126682750, 127344623, 127344624, 129283027, 134339256, 134342635, 135066836, 137125051, 137746906, 152106684, 198988688, 223655254, 227838925, 250116288, 252156842, 252215270, 252333760, 252467322
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Emerging treatments for traumatic brain injury. Expert Opin Emerg Drugs. 2009 Mar;14(1):67-84. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.